Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 44,650
-1,150 (-2.51%)
Oct 8, 2026, 10:10 AM KST
Hanall Biopharma Market Cap
Hanall Biopharma has a market cap or net worth of 2.27 trillion as of October 7, 2026. That makes Hanall Biopharma the world's 7,425th most valuable company and 192nd in South Korea. Its market cap has increased by 29.68% in one year.
Market Cap
2.27T
Enterprise Value
2.29T
Revenue
162.66B
Global Rank
Country Rank
#192 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 2.27T, an increase of 8,534.52%. That is a compound annual growth rate of 15.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 2.27T | 2.21% |
| Dec 30, 2025 | 2.22T | 13.35% |
| Dec 30, 2024 | 1.96T | -12.72% |
| Dec 28, 2023 | 2.25T | 148.89% |
| Dec 29, 2022 | 902.29B | -16.29% |
| Dec 30, 2021 | 1.08T | -43.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hanmi Pharm. | 6.42T |
| Yuhan | 5.53T |
| Celltrion Pharm | 1.70T |
| GC Biopharma | 1.44T |
| Daewoong Pharmaceutical | 1.25T |
| Chong Kun Dang Pharmaceutical | 859.08B |
| Boryung | 708.34B |
| Daewoong | 644.85B |